About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Pfizer Ends Its "Unwritten Rule": Don't Return Reporters' Calls

By Jim Edwards | Feb 5, 2009

Pfizer pr chief Ray Kerins said that Pfizer had an “unwritten rule” for dealing with the media: Don’t return reporters’ calls. Here’s what Ad Age says he told the Business Development Institute’s Real-Time Communications Conference:

Back in 2007, on the second day of his new job as Pfizer’s global PR chief, Ray Kerins said he was told of an unwritten rule: ignore the first message received from any reporter on any given issue.

Oddly, although Ad Age has video of Kerins’ speech, it doesn’t have that snippet. They do have Kerins describing how Pfizer pr folk figured out that not returning calls doesn’t help the company’s corporate rep. Kerins:

… if we’re not willing to engage we only have ourselves to blame. I blame myself and those of us in the industry for the bad reputation that the pharma industry has. We develop life-saving medicines that you take, that will prolongue your life … how in hell do we have such a bad reputation? It makes no sense.

Pfizer’s inability to deal with the media did not go unnoticed. In fact, it actually drew more attention to the company’s dysfunctional PR. In a previous job I noted:

Note to Pfizer pr Pfolks: Guys, not every story has to be bad news. … Try picking up the phone. Transparency is a powerful thing. Just because you’re not talking doesn’t mean all my other sources disappear — why give them all that free mileage?

Having said that, no amount of good pr will wash away headline makers such as Pfizer’s takeover of Wyeth. Bloomberg:

Pfizer, based in New York, said 19,500 jobs will be eliminated from the combined companies. The deal is financed by $22.5 billion in loans from banks that received at least $75 billion from the Treasury Department’s rescue plan, the drugmaker said on Jan. 26.

Unsurprisingly, there are already protests that this job-killing deal “perverts” the purpose of the TARP funds.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Pfizer PR Chief's Tips for Managing Journalists

    Ad Age - 293 days 12 hours 39 minutes ago

    NEW YORK (AdAge.com) -- In 2007, on the second day of his new job as Pfizer's global PR chief, Ray Kerins said he was told of an unwritten rule: ignore the first message received from any reporter on any given issue. He told that story at the recent Business Development Institute's Real-Time Communications Conference. But he also detailed how,...

  • Pfizer Asks Media Members: How Are We Doing?

    BNET Pharma - 287 days 17 hours 22 minutes ago

    Pfizer is polling about 250 members of the media to find out whether its PR operations are any good. The move appears to be part of Pfizer PR chief Ray Kerins' drive to change Pfizer's image from a Kremlin-esque castle of puzzles into a more communicative, forthright enterprise. Kerins recently complained about Pfizer's now-discontinued...

  • Pfizer Exec Says FDA's Lack of Social Media Guidance Is "a Problem"

    BNET Pharma - 84 days 19 hours 50 minutes ago

    Pfizer PR chief Ray Kerins blasted the FDA's lack of guidance on social media as "a problem" at a recent conference: "There actually are no

  • Merck CEO open to big-time M&A

    Fierce Pharma - 292 days 23 hours 5 minutes ago

    Merck CEO Richard Clark (photo) set tongues wagging yesterday when he told analysts that the company would consider a big M&A deal. "I don't think any CEO in this environment can categorically rule out any transaction," he said, adding that he was looking at the "entire spectrum" of deals. That's a turnabout for Merck, which traditionally has...

  • Google Analytics Exec Tells Mags to Get Web Smart

    Ad Age - 265 days 18 hours ago

    NEW YORK (AdAge.com) -- Magazine websites still seem preoccupied with selling print subscriptions, but don't know how to make the most of their content, a Google executive told a magazine conference today. "That sort of made me sad," he said, "because that is your strategic advantage."

 
Reply to Story

BNET TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via Email or RSS

  •  
    1

    BNET's Jim Edwards

    02/06/09 | Report as spam

    RE: Pfizer Ends Its ?Unwritten Rule?: Don?t Return Reporters? Calls

    From Ray Kerins:

    Jim,

    Thanks for your post. Not sure what your working relationship has been in the past with Pfizer, but hopefully it has improved via mutual respect for each other jobs. Regarding the proposed transaction with Wyeth we do believe that the combination of these complementary industry leading businesses establishes the premier diversified global biopharmaceutical company; well positioned for long-term growth. Let me know if you want to get together and discuss this topic or any other.

    Ray Kerins

    Pfizer

  •  
    2

    BNET's Jim Edwards

    02/06/09 | Report as spam

    RE: Pfizer Ends Its ?Unwritten Rule?: Don?t Return Reporters? Calls

    To be fair: It has improved a little. I did notice calls and emails got responses more in the last 6 months.

    I particularly appreciated the reversal of the old policy of not allowing Pfizer brand managers to talk to the press.

    Jim

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here